About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Screening System to Evolve Safer Drugs for Combating Leishmaniasis

by Medindia Content Team on October 4, 2007 at 3:55 PM
Font : A-A+

New Screening System to Evolve Safer Drugs for Combating Leishmaniasis

This week, Biotechnology and Biological Sciences Research Council (BBSRC) has drawn attention to the new screening system developed for new, safer drugs by the scientists at the University of Durham in their fight against Leishmaniasis, commonly known as black fever.

Leishmaniasis is a parasitic disease found largely in the tropics, which the World Health Organisation has estimated, infects 12 million people worldwide each year. In the tropical regions Leishmaniasis is transmitted by sandflies but more recently cases have been reported in Europe among intravenous drug users with HIV. The parasite is a protozoan, a single-celled microbe, which causes symptoms ranging from skin sores to a swollen spleen or liver. If not treated, the more damaging forms of the disease can lead to death.

Advertisement

Many drugs against these types of parasites have toxic side effects, and can result in the death of one in ten patients. Development of safe treatments has been hampered up by the similarity between the biochemical processes of the pathogen and its human host.

However, researchers at Durham University have now developed a screening system to provide new insight into the biochemical processes at play. As a result they have identified and characterised a key enzyme which helps produce an essential cell component of protozoa called a 'complex sphingolipid', plus an inhibitor, which specifically acts against this enzyme. The team has recently filed a patent for the system, which could be used in the search for non-toxic anti-protozoan drugs.
Advertisement

Dr Paul Denny, research leader, explains: "Identifying both the enzyme responsible for the complex sphingolipid component of protozoa plus the inhibitor which acts against this enzyme is very significant. It has marked implications in the search for anti-protozoan drugs with reduced side-effects, as knowing how to block this enzyme could prevent the production of the complex sphingolipid and thus prevent the protozoa from establishing infection.

"Potentially we can rapidly screen thousands of compounds for inhibitory effects against this enzyme. It provides a much quicker means of identifying inhibitors with the potential for drug development than is standard.

"Our next step is to understand the structure and mechanism of this enzyme to help inform rational drug design."

The research is supported by BBSRC. Prof Nigel Brown, BBSRC Director of Science and Technology commented: "Leishmaniasis is an extremely damaging disease which threatens 350 million people in 88 countries around the world. This research demonstrates how important fundamental bioscience research is to developing life-saving pharmaceuticals, and should provide hope to people in affected regions."

Source: Eurekalert
GAN/C
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
Fermented Skin Care
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Leishmaniasis Drugs Banned in India 

Recommended Reading
Leishmaniasis serological test
Leishmaniasis serological test to diagnose Kala-azar. Leishmania donovani infects spleen, bone ......
North Texas Leishmaniasis Outbreak Identified by Dermatologists
Nine North Texas cases of an infectious skin disease common in South America, Mexico and in the ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Leishmaniasis
Leishmaniasis (Kala-azar) refers to the spectrum of infectious disease produced by species of the Le...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)